These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16358922

  • 1. [Medical management of chronic rhinosinusitis with macrolides].
    Górski NP, Krzeski A.
    Pol Merkur Lekarski; 2005 Sep; 19(111):490-3. PubMed ID: 16358922
    [Abstract] [Full Text] [Related]

  • 2. Chronic rhinosinusitis and eosinophils: do macrolides have an effect?
    Wallwork B, Coman W.
    Curr Opin Otolaryngol Head Neck Surg; 2004 Feb; 12(1):14-7. PubMed ID: 14712113
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.
    Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A.
    Laryngoscope; 2006 Feb; 116(2):189-93. PubMed ID: 16467702
    [Abstract] [Full Text] [Related]

  • 4. Macrolide therapy of chronic rhinosinusitis.
    Cervin A, Wallwork B.
    Rhinology; 2007 Dec; 45(4):259-67. PubMed ID: 18085018
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis.
    Harvey RJ, Wallwork BD, Lund VJ.
    Immunol Allergy Clin North Am; 2009 Nov; 29(4):689-703. PubMed ID: 19879444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis.
    Wei JL, Kita H, Sherris DA, Kern EB, Weaver A, Ponikau JU.
    Laryngoscope; 2003 Feb; 113(2):303-6. PubMed ID: 12567086
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis.
    Cervin A, Wallwork B, Mackay-Sim A, Coman WB, Greiff L.
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):136-42. PubMed ID: 19076731
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impaired mucociliary clearance in allergic rhinitis patients is related to a predisposition to rhinosinusitis.
    Vlastos I, Athanasopoulos I, Mastronikolis NS, Panogeorgou T, Margaritis V, Naxakis S, Goumas PD.
    Ear Nose Throat J; 2009 Apr; 88(4):E17-9. PubMed ID: 19358114
    [Abstract] [Full Text] [Related]

  • 16. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 17. [Chronic rhinosinusitis--new concept of macrolide treatment].
    Xu G, Wang DY.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):3-5. PubMed ID: 19484979
    [No Abstract] [Full Text] [Related]

  • 18. Judicious antibiotic use and intranasal corticosteroids in acute rhinosinusitis.
    Small CB, Bachert C, Lund VJ, Moscatello A, Nayak AS, Berger WE.
    Am J Med; 2007 Apr; 120(4):289-94. PubMed ID: 17398218
    [Abstract] [Full Text] [Related]

  • 19. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma.
    Pedroletti C, Lundahl J, Alving K, Hedlin G.
    Pediatr Allergy Immunol; 2008 May; 19(3):219-26. PubMed ID: 18399898
    [Abstract] [Full Text] [Related]

  • 20. Allergic rhinitis and rhinosinusitis.
    Ahmad N, Zacharek MA.
    Otolaryngol Clin North Am; 2008 Apr; 41(2):267-81, v. PubMed ID: 18328367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.